Kalshi Extends Bets to Drug Trials and Regulatory Outcomes
Kalshi is piloting bets on drug-trial results and FDA regulatory decisions (in partnership with AppliedXL) to surface publicly updated trial probabilities and improve information flow, with safeguards like employment verification; it’s also evaluating a separate flight-cancellation contract, signaling ongoing growth in prediction markets despite scrutiny over manipulation.